Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 June 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Primary care physicians need help to identify HCV risk

Researchers in America have called for better mechanisms to enable doctors to identify those at risk of Hepatitis C and ensure they get tested while there is still time for treatment.

News image

fiogf49gjkf04

The call follows new research that shows people infected with the potential fatal virus are not getting tested early enough or often enough, and are not always being referred for specialty care.

The research, by University of Michigan Health System, found that among a sample of the 2,348 HCV screening tests ordered by primary care physicians, only a quarter were ordered because the doctor identified the patient as having a potential risk factor. The risk factors included intravenous drug use or a blood transfusion before 1992.

Another 65% had the test because of prior liver problems, or because routine blood tests showed elevated liver enzymes. 10% of patients requested it.

Of all those tested, 10% turned out to be infected, and about half were referred to a specialist for follow-up.

Meanwhile, almost half of the 57 patients who tested positive and went on to have a liver biopsy had significant liver scarring - either cirrhosis or fibrosis - suggesting a long-standing infection.

Primary care doctors need to investigate HCV risk factors in patients.
Digestive Disease Week

The results of the study were presented at the Digestive Disease Week meeting in Atlanta.

University of Michigan Medical School gastroenterology professor, Dr Anna Lok, said primary care doctors were the gatekeepers of the health care system, and it was crucial they caught the infection early by asking about risk factors, ordering tests, and referring those who test positive for evaluation and treatment.

She commented that patients were also responsible for volunteering the information to their doctors, despite the perceived stigma of the virus.

University fellow, Dr Thomas Shehab, said general physicians were being expected to screen for more and more diseases, and the results showed that they needed help to do it in a way that was efficient and effective.

The study contradicted the views of many primary care physicians, who thought they did a good job of assessing patients for their hepatitis C risk and referring them for treatment.

The new study did not examine why a higher percentage of patients were not tested based on risk factors, or what reasons might have stopped them getting a referral, such as a patient's age or other health problems.

"Ideally, early diagnosis can be made if doctors ask about hepatitis C risk factors and patients answer honestly. We shouldn't wait until patients have symptoms, or until the infection has progressed, as treatment is often more effective if it's begun earlier," said Dr Lok.

"In addition, there are important potential benefits to the public at large of early diagnosis. These include the fact that hepatitis C patients may change behaviors and therefore reduce the risk of transmission to others, and the possibility that they may modify practices such as alcohol consumption that may alter the disease's progression."

The researchers hope to add screening questions about HCV risk factors to questionnaires handed to patients in primary care clinics, or to find ways to use technology to make the process more efficient.

Report Copyright: Englemed Health News at http://www.internationalmedicalnews.com

Digestive Disease Week
25 May 2001

Go to top of page Email this page Email this page to a colleague

 31 May 2018 
Diagnostic for NAFLD  
 31 May 2018 
Bile acids and the risks for hepatotoxicity
 31 May 2018 
Rectal cancer female sexuality score
 30 May 2018 
Fungal dysbiosis in cirrhosis
 30 May 2018 
Placebo rates in ulcerative colitis trials
 30 May 2018 
Follow-up testing and colorectal cancer mortality
 29 May 2018 
Organ transplantation donors
 29 May 2018 
Novel therapies for IBD
 29 May 2018 
Helicobacter pylori infection to stomach cancer
 28 May 2018 
Mesalazine in ulcerative colitis
 28 May 2018 
Technology and management of digestive diseases
 28 May 2018 
Therapeutic strategies for HCV
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Chronic Hep B
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
European guidelines on pancreatic cystic neoplasms

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us